How is Nivolumab administered?

Nivolumab is administered intravenously, which means it is delivered directly into the bloodstream through a vein. This method is commonly used for certain types of immunotherapy medications, as intravenous administration allows for controlled dosing and rapid distribution throughout the body. Nivolumab is an immune checkpoint inhibitor that helps enhance the body’s immune response against cancer cells, and intravenous delivery is optimal for ensuring the medication reaches its intended targets effectively.

Other routes of administration, such as orally, subcutaneously, or topically, are not suitable for Nivolumab due to the nature of how the drug functions and the requirement for high bioavailability in the bloodstream to exert its therapeutic effects. Intravenous administration is particularly advantageous for biologic agents like Nivolumab, as it bypasses issues of digestion and absorption that can occur with oral medications.